Fractyl Health, Inc. (GUTS) Financials

GUTS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 99.4 million 78.0 million
Dec. 31, 2025 121.4 million 111.9 million
Sept. 30, 2025 114.3 million 117.5 million
June 30, 2025 62.0 million 80.2 million

GUTS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -22.5 million 2.5 million
Dec. 31, 2025 -21.3 million 1.9 million
Sept. 30, 2025 -22.7 million 1.6 million
June 30, 2025 -21.3 million 1.8 million

GUTS Net Income

No data available :(

GUTS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 63.2 million 55.7 million -
Dec. 31, 2025 81.5 million 30.6 million 26.0 million
Sept. 30, 2025 77.7 million 30.8 million 26.3 million
June 30, 2025 22.3 million 30.0 million 31.7 million

GUTS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 158.5 million
Dec. 31, 2025 75.8 million
Sept. 30, 2025 64.7 million
June 30, 2025 49.0 million

GUTS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 15.6 million 5.2 million -
Dec. 31, 2025 3000 16.5 million 6.8 million -
Sept. 30, 2025 8000 17.5 million 5.2 million -
June 30, 2025 98000 21.2 million 4.9 million -

GUTS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - 279000
Sept. 30, 2025 - 290000
June 30, 2025 - 270000

GUTS

Price: $0.77

52 week price:
0.38
2.45

Earnings Per Share: -1.31 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 57.5 million

Links: